Fintel reports that on March 17, 2025, Lake Street initiated coverage of Axogen (NasdaqCM:AXGN) with a Buy recommendation.
Some big news could be just days away for this growing regenerative medicine company. The post Orthocell shares up 10% today; anticipates FDA approval in the coming weeks appeared first on The Motley ...